Inhaled corticosteroids in severe COPD

Lancet Respir Med. 2013 May;1(3):177-8. doi: 10.1016/S2213-2600(13)70042-0. Epub 2013 Apr 15.
No abstract available

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / adverse effects
  • Androstadienes* / administration & dosage
  • Androstadienes* / adverse effects
  • Benzyl Alcohols* / administration & dosage
  • Benzyl Alcohols* / adverse effects
  • Chlorobenzenes* / administration & dosage
  • Chlorobenzenes* / adverse effects
  • Fluticasone
  • Humans
  • Medication Therapy Management
  • Outcome Assessment, Health Care
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-Agonists
  • Androstadienes
  • Benzyl Alcohols
  • Chlorobenzenes
  • vilanterol
  • Fluticasone